Traditional echocardiograms could help measure cardiovascular stiffness

AHA会议
Researchers at the University of Missouri College of Engineering say they used data from echocardiograms to measure cardiovascular stiffness. Using the data from traditional echocardiograms, the researchers say they could measure the rigidity of the arteries in the heart. Currently, according to the researchers, no clinical way for doctors to measure aortic stiffness exists. Pulse wave velocity tests (PWV) have been used to measure this metric, but only in research settings. The research team believes their method could revolutionize precision heart healthcare, according to the University of Missouri website. “I consider this the most important work I’ve done in my career,” said Noah Manring, a professor of mechanical and aerospace engineering. “We have an incredible opportunity to collaborate with cardiologists and physicians to implement this into monitoring that’s already being done to provide better, more precise information to help determine treatment options.” Maggie Oliver, a postdoctoral student in mechanical engineering working with Manring on the project, said PWV is seen as the gold standard. However, it only measures how quickly pressure waves generated by the heartbeat travel along the arteries, she said. Without any standardization of the method, even if hospitals adopted PWV, health insurance would not cover it. The Missouri team published preliminary data on their potentially revolutionary method in the American Society of Mechanical Engineers’ Journal of Engineering and Science in Medical Diagnostics and Therapy. It provides data from echocardiograms in a small sample of patients at University Hospital. The team said its method expresses mean arterial pressure as the product of cardiac output and peripheral resistance. “Our method is actually better, not only because you can extract the aortic stiffness measurement from existing data, but also because it provides more precise data,” Manring said. “The methods developed in this research use standard clinical examinations that are routinely paid for by insurance, so it would extend the benefits of total cardiovascular assessment to a much wider patient group.”
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。